To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.
The bill’s titles are written by its sponsor.
Mar 21, 2013
113th Congress, 2013–2015
Died in a previous Congress
This bill was introduced on March 21, 2013, in a previous session of Congress, but was not enacted.
Representative for Massachusetts's 8th congressional district
Read Text »
Last Updated: Mar 21, 2013
Length: 2 pages
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 1366 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). H.R. 1366 — 113th Congress: Stop Oxy Abuse Act of 2013. Retrieved from https://www.govtrack.us/congress/bills/113/hr1366
“H.R. 1366 — 113th Congress: Stop Oxy Abuse Act of 2013.” www.GovTrack.us. 2013. June 26, 2017 <https://www.govtrack.us/congress/bills/113/hr1366>
|title=H.R. 1366 (113th)
|accessdate=June 26, 2017
|author=113th Congress (2013)
|date=March 21, 2013
|quote=Stop Oxy Abuse Act of 2013
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.